Paolo Lusso Selected Research

Paolo Lusso Research Topics

Disease

33	Infections 01/2022 - 05/2002
11	Acquired Immunodeficiency Syndrome (AIDS) 12/2021 - 05/2002
6	Disease Progression 05/2017 - 12/2002
4	Viremia 11/2013 - 09/2002
3	HIV Infections (HIV Infection) 01/2017 - 05/2002
2	Coinfection 11/2020 - 07/2009
2	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2016 - 09/2002
1	Paramyxoviridae Infections (Parainfluenza) 05/2022
1	COVID-19 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Superinfection 11/2020
1	Hepatitis 11/2020
1	Hepatitis B 11/2020
1	Opportunistic Infections (Opportunistic Infection) 12/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Type IIB Congenital Disorder Of Glycosylation 04/2014
1	Agammaglobulinemia (Hypogammaglobulinemia) 04/2014
1	Rheumatoid Arthritis 11/2013
1	Discoid Lupus Erythematosus 11/2013
1	Systemic Scleroderma (Systemic Sclerosis) 11/2013
1	Dermatomyositis (Dermatopolymyositis) 11/2013
1	Connective Tissue Diseases (Connective Tissue Disease) 11/2013
1	Autoimmune Diseases (Autoimmune Disease) 11/2013
1	Myocardial Infarction 12/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2012
1	Atherosclerosis 12/2012
1	Exanthema (Rash) 04/2012
1	Hypersensitivity (Allergy) 04/2012
1	Virus Diseases (Viral Diseases) 12/2011
1	Dermatitis 05/2008
1	Fetal Death 05/2008

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 05/2022 - 05/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
6	CytokinesIBA 11/2020 - 08/2003
6	ChemokinesIBA 09/2015 - 05/2002
5	Antiviral Agents (Antivirals)IBA 09/2015 - 05/2002
5	Chemokine CCL5IBA 07/2010 - 06/2002
4	AntibodiesIBA 05/2022 - 12/2011
4	LigandsIBA 01/2020 - 06/2002
4	AntigensIBA 11/2013 - 06/2005
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2012
3	Glycoproteins (Glycoprotein)IBA 12/2013 - 02/2006
3	CC ChemokinesIBA 06/2008 - 06/2002
2	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2021 - 12/2006
2	Interleukin-2 (IL2)IBA 11/2020 - 09/2002
2	IntegrinsIBA 01/2020 - 05/2017
2	EnzymesIBA 01/2017 - 04/2014
2	Peptides (Polypeptides)IBA 08/2016 - 04/2007
2	Viral DNAIBA 05/2016 - 11/2013
2	Anti-Infective Agents (Microbicides)IBA 10/2013 - 07/2010
2	Interleukin-7 (Interleukin 7)IBA 01/2012 - 02/2007
2	Chemokine CCL4IBA 07/2010 - 06/2008
2	RNA (Ribonucleic Acid)IBA 01/2009 - 01/2008
2	Chemokine ReceptorsIBA 02/2006 - 12/2002
1	COVID-19 VaccinesIBA 05/2022
1	IgA receptor (protein B)IBA 05/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	P-SelectinIBA 01/2022
1	mRNA VaccinesIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Interleukin-10 (Interleukin 10)IBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Interleukin-5 (Interleukin 5)IBA 11/2020
1	Interleukin-4 (Interleukin 4)IBA 11/2020
1	Interleukin-15 (Interleukin 15)IBA 11/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	OccludinIBA 01/2018
1	CalciumIBA 01/2018
1	Claudin-1IBA 01/2018
1	Cell Adhesion Molecule-1IBA 05/2017
1	IntegrasesIBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017
1	HIV ProteaseIBA 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 08/2016
1	Antineoplastic Agents (Antineoplastics)IBA 05/2016
1	Alanine (L-Alanine)FDA Link 09/2015
1	glucosidase IIBA 04/2014
1	Immunoglobulins (Immunoglobulin)IBA 04/2014
1	OligosaccharidesIBA 04/2014
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2013
1	Immunoglobulin G (IgG)IBA 11/2013
1	CXC ChemokinesIBA 06/2012
1	Pharmaceutical PreparationsIBA 04/2012
1	Antimicrobial PeptidesIBA 01/2012
1	Protein Subunits (Protein Subunit)IBA 12/2011
1	Local Anti-Infective Agents (Antiseptics)IBA 11/2009
1	beta-Galactosidase (Lactaid)IBA 01/2009
1	LuciferasesIBA 01/2009
1	Chemokine CCL3IBA 06/2008
1	ParaffinIBA 05/2008
1	Dihydrotachysterol (AT 10)IBA 05/2008
1	alpha-DefensinsIBA 04/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2007

Therapy/Procedure

6	Therapeutics 01/2021 - 05/2002
1	Hematopoietic Stem Cell Transplantation 12/2018
1	Cell Transplantation 12/2018
1	Art Therapy 01/2012